AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ACIDE FUSIDIQUE+BETAMETHASONE

10 registrations across 3 African markets— 3 active

Markets with ACIDE FUSIDIQUE+BETAMETHASONE

Recent registrations

Brand / ProductMarketHolderStatusExpires
FUSICIN PLUS
Creme dermique / 2% / 0.1%
🇹🇳TunisiaDAR-ESSAYDALI.expiredFeb 2023
TRICIDINE PLUS
Creme dermique / 2% / 0.1%
🇹🇳TunisiaWEST PHARMAexpiredDec 2021
ZYDEX B
Creme dermique
🇹🇳TunisiaBEIT JALA Pharmaceutical CoexpiredJul 2021
FUCICORT 20MG/G/1MG/G CREME TUBE DE 15G🇨🇮Côte d'IvoireLABORATOIRE LEO PHARMA A/SexpiredJan 2021
TRICIDINE PLUS
Creme dermique / 2% / 0.1%
🇹🇳TunisiaWEST PHARMAexpiredJul 2018
AFUSIDIC PLUS
Creme dermique / 2%
🇹🇳TunisiaOPALIA PHARMAexpiredMay 2007
UCIDERM PLUS
Creme dermique
🇹🇳TunisiaSIMEDexpiredJul 2004
DISUF-B
crème dermique / 0,1% / 2%
🇸🇳SenegalHOVID HHDactive
FUCICORT
CREME / 20mg/1mg
🇸🇳SenegalLEO PHARMAactive
FUCICORT
CREME / 20mg/1mg
🇸🇳SenegalLEO PHARMAactive

ACIDE FUSIDIQUE+BETAMETHASONE in Africa — Regulatory Overview

ACIDE FUSIDIQUE+BETAMETHASONE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Senegal, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 3 (30%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.